What you do not know about a target company can cost you everything. Our Boston due diligence attorneys conduct rigorous legal due diligence for business acquisitions across Biotech, Healthcare, Technology, identifying hidden risks and liabilities so you can make informed decisions and negotiate from a position of strength.
Our managing partner provides selective acquisition due diligence law counsel to clients in Boston and nationwide, including:
We engage selectively with capitalized founders and investors in Boston and nationwide:
Boston is the global epicenter of biotech and life sciences M&A, with Kendall Square and the Route 128 corridor housing the densest concentration of biotech companies outside San Francisco. Beyond life sciences, the region drives significant deal activity in financial technology, education technology, and defense contracting. The region's deep research university ecosystem (MIT, Harvard, Tufts) produces a steady stream of spinoff companies ripe for acquisition.
Boston's biotech-heavy deal market means acquirers often face complex IP due diligence involving university licenses, clinical trial data, and FDA regulatory considerations. Competition from large pharma strategic acquirers can push valuations higher for promising targets.
Boston's concentration of world-class research institutions and highly educated workforce creates a self-reinforcing ecosystem where acquired companies can access talent, partnerships, and capital unavailable in other markets.
Massachusetts enacted the Noncompetition Agreement Act in 2018, limiting non-competes to 12 months and requiring garden leave pay - buyers must evaluate existing employee agreements during due diligence as many pre-2018 agreements may now be unenforceable.
We specialize in biotech and life sciences securities transactions, understanding the unique regulatory and scientific complexities of this sector.
A structured, methodical approach to acquisition due diligence law
We create a customized due diligence checklist and request list based on the target company's industry, size, and deal structure, then coordinate document collection with the seller.
Our team reviews every material contract, corporate record, litigation file, and regulatory filing in the data room, flagging risks that could affect valuation or deal terms.
We identify and categorize risks by severity, including potential liabilities, contract issues, compliance gaps, and operational exposures that require attention before closing.
Managing Partner Alex Lubyansky delivers a clear, actionable findings report with risk-ranked issues and specific recommendations for how to address each one in the purchase agreement.
We translate diligence findings into negotiation leverage, drafting specific representations, warranties, indemnities, and closing conditions that protect you from identified risks.
"If you don't qualify aggressively on the front end, what a terrible waste of time. The other party might not have actual funding, they might not have actual backing, they might not have actual intent. They're just using the deal as a way to gain free market information."
Restricted with 12-month cap and garden leave requirement. Sale-of-business exception.
Entity mergers and conversions require filing with the Massachusetts Secretary of the Commonwealth, Corporations Division. The Department of Revenue requires tax waivers for asset purchases. Professional corporations require additional filings with the relevant licensing board.
Submit your transaction details for a preliminary assessment by our managing partner.
Your transaction details are under review. If there is alignment, we will be in touch.
Meanwhile, feel free to call us directly at (248) 266-2790
Common questions from Boston clients
Submit your transaction details for a preliminary assessment by our managing partner
Submit Transaction DetailsIn-depth guides to help you prepare for your transaction
Key considerations for sellers navigating the M&A process with legal representation.
Read guideA structured approach to legal, financial, and operational due diligence.
Read guideUnderstanding the binding and non-binding elements of each document.
Read guideCommon deal-killers and how experienced counsel helps prevent them.
Read guideWhat buyers should look for in a Franchise Disclosure Document.
Read guideOur managing partner provides selective acquisition due diligence law counsel for transactions nationwide. Submit your transaction details for a preliminary assessment.
Submit transaction details for review. We engage selectively with capitalized buyers and sellers.
Your transaction details are under review. If there is alignment, we will be in touch.
Meanwhile, feel free to call us directly at (248) 266-2790
Selective M&A practice - Nationwide reach - Managing partner on every deal